This panel session will discuss why you should know about point-of-care fluorescence imaging (MolecuLight) of bacterial location and load, a revolutionary tool that is breaking barriers in wound assessment and treatment decisions.
The panel will present evidence for and examples of imaging reducing racial disparities in wound management from a clinical trial of 350 patients. The panel will also present evidence for imaging-informed treatment decisions improving outcomes in long-term care/skilled nursing facilities, giving light to this vulnerable population.
Sponsored by MolecuLight.
***** Innovation Theaters are informational sessions designed to complement the educational experience by further enhancing knowledge and confidence of disease-states or products. Innovation Theaters are non-accredited and no CME/CE credits are offered at these programs.
This session is complimentary for registered SAWC Spring attendees; however, additional registration is required. To add this session to your existing registration: Visit the registration page / select “Get Log in Link”/ “Edit Registration”/navigate through the registration until the “Additional Products” page/add the session to your registration. For questions, please contact email@example.com. Space is limited and available on a first-come, first-served basis. *****
Learn about point-of-care fluorescence imaging and what can it bring to your practice
Learn how presentation of infection signs and symptoms vary across skin pigmentations and how that limitation can be overcome with imaging advances
Learn how imaging has changed the care of complex wound patients in LTC/SNFs